March 25 (Reuters) - Mesoblast Ltd (MSB) :
- MESOBLAST LICENSEE FILES FOR MARKETING APPROVAL TO TREAT EPIDERMOLYSIS BULLOSA
News: MSB Mesoblast Licensee Files For Marketing Approval To Treat Epidermolysis Bullosa
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
-0.090(5.71%) |
Mkt cap ! $1.113B | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.59 | $1.47 | $7.056M | 4.697M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3999 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 46134 | 7 |
View Market Depth
| Last trade - 16.10pm 21/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
